Shoji Yamazaki

24-Hour Blood Pressure-Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: Results from the Randomized, Placebo-Controlled SACRA Study.

K. Kario, T. Katsuya, Mitsutoshi Kato, 2018, Circulation.

Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension

K. Kario, T. Katsuya, Mitsutoshi Kato, 2018, Circulation.

Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER‐1 study

K. Kario, N. Tomitani, Hiroshi Kanegae, 2019, Journal of clinical hypertension.